Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023

Author: Benzinga Insights | February 21, 2023 11:00am

Upgrades

According to BMO Capital, the prior rating for Focus Financial Partners Inc (NASDAQ:FOCS) was changed from Market Perform to Outperform. Focus Finl Partners earned $0.99 in the fourth quarter, compared to $0.94 in the year-ago quarter. The stock has a 52-week-high of $53.53 and a 52-week-low of $30.27. At the end of the last trading period, Focus Finl Partners closed at $50.12.

Guggenheim upgraded the previous rating for Alliant Energy Corp (NASDAQ:LNT) from Sell to Neutral. In the third quarter, Alliant Energy showed an EPS of $0.93, compared to $1.02 from the year-ago quarter. The stock has a 52-week-high of $65.37 and a 52-week-low of $47.19. At the end of the last trading period, Alliant Energy closed at $53.97.

According to Janney Montgomery Scott, the prior rating for HomeTrust Bancshares Inc (NASDAQ:HTBI) was changed from Neutral to Buy. For the second quarter, HomeTrust Bancshares had an EPS of $0.90, compared to year-ago quarter EPS of $0.68. The stock has a 52-week-high of $31.11 and a 52-week-low of $21.55. At the end of the last trading period, HomeTrust Bancshares closed at $28.07.

According to Raymond James, the prior rating for Glacier Bancorp Inc (NYSE:GBCI) was changed from Market Perform to Outperform. Glacier Bancorp earned $0.72 in the fourth quarter, compared to $0.46 in the year-ago quarter. The current stock performance of Glacier Bancorp shows a 52-week-high of $59.70 and a 52-week-low of $44.32. Moreover, at the end of the last trading period, the closing price was at $47.15.

Wedbush upgraded the previous rating for Travere Therapeutics Inc (NASDAQ:TVTX) from Neutral to Outperform. In the third quarter, Travere Therapeutics showed an EPS of $0.76, compared to $0.13 from the year-ago quarter. At the moment, the stock has a 52-week-high of $30.35 and a 52-week-low of $17.82. Travere Therapeutics closed at $17.82 at the end of the last trading period.

Raymond James upgraded the previous rating for Trustmark Corp (NASDAQ:TRMK) from Market Perform to Outperform. For the fourth quarter, Trustmark had an EPS of $0.68, compared to year-ago quarter EPS of $0.42. The stock has a 52-week-high of $38.47 and a 52-week-low of $26.67. At the end of the last trading period, Trustmark closed at $29.66.

According to Raymond James, the prior rating for Prosperity Bancshares Inc (NYSE:PB) was changed from Market Perform to Outperform. Prosperity Bancshares earned $1.51 in the fourth quarter, compared to $1.38 in the year-ago quarter. At the moment, the stock has a 52-week-high of $78.76 and a 52-week-low of $64.69. Prosperity Bancshares closed at $75.02 at the end of the last trading period.

For Lakeland Financial Corp (NASDAQ:LKFN), Raymond James upgraded the previous rating of Market Perform to Outperform. Lakeland Financial earned $1.01 in the fourth quarter, compared to $0.95 in the year-ago quarter. At the moment, the stock has a 52-week-high of $83.57 and a 52-week-low of $64.05. Lakeland Financial closed at $70.94 at the end of the last trading period.

According to B. Riley Securities, the prior rating for MarineMax Inc (NYSE:HZO) was changed from Neutral to Buy. In the first quarter, MarineMax showed an EPS of $1.24, compared to $1.59 from the year-ago quarter. The current stock performance of MarineMax shows a 52-week-high of $48.67 and a 52-week-low of $27.40. Moreover, at the end of the last trading period, the closing price was at $33.55.

For Norfolk Southern Corp (NYSE:NSC), Wolfe Research upgraded the previous rating of Peer Perform to Outperform. For the fourth quarter, Norfolk Southern had an EPS of $3.42, compared to year-ago quarter EPS of $3.12. The stock has a 52-week-high of $291.55 and a 52-week-low of $203.65. At the end of the last trading period, Norfolk Southern closed at $228.15.

For Caleres Inc (NYSE:CAL), Piper Sandler upgraded the previous rating of Neutral to Overweight. For the third quarter, Caleres had an EPS of $1.15, compared to year-ago quarter EPS of $1.59. The current stock performance of Caleres shows a 52-week-high of $31.13 and a 52-week-low of $17.82. Moreover, at the end of the last trading period, the closing price was at $25.95.

According to Goldman Sachs, the prior rating for Vir Biotechnology Inc (NASDAQ:VIR) was changed from Neutral to Buy. In the third quarter, Vir Biotechnology showed an EPS of $1.30, compared to $0.82 from the year-ago quarter. The current stock performance of Vir Biotechnology shows a 52-week-high of $32.44 and a 52-week-low of $18.05. Moreover, at the end of the last trading period, the closing price was at $25.74.

See all analyst ratings upgrades.

Downgrades

Raymond James downgraded the previous rating for Origin Bancorp Inc (NASDAQ:OBNK) from Strong Buy to Outperform. For the fourth quarter, Origin Bancorp had an EPS of $0.99, compared to year-ago quarter EPS of $1.20. The stock has a 52-week-high of $47.28 and a 52-week-low of $35.36. At the end of the last trading period, Origin Bancorp closed at $39.64.

Argus Research downgraded the previous rating for Annaly Capital Management Inc (NYSE:NLY) from Buy to Hold. For the fourth quarter, Annaly Capital Management had an EPS of $0.89, compared to year-ago quarter EPS of $1.12. At the moment, the stock has a 52-week-high of $29.88 and a 52-week-low of $15.11. Annaly Capital Management closed at $21.59 at the end of the last trading period.

According to Compass Point, the prior rating for Kinsale Capital Group Inc (NYSE:KNSL) was changed from Buy to Neutral. Kinsale Capital Gr earned $2.60 in the fourth quarter, compared to $1.76 in the year-ago quarter. The stock has a 52-week-high of $337.12 and a 52-week-low of $187.03. At the end of the last trading period, Kinsale Capital Gr closed at $334.31.

Raymond James downgraded the previous rating for Axos Financial Inc (NYSE:AX) from Strong Buy to Outperform. For the second quarter, Axos Financial had an EPS of $1.38, compared to year-ago quarter EPS of $1.04. The stock has a 52-week-high of $55.66 and a 52-week-low of $33.91. At the end of the last trading period, Axos Financial closed at $50.24.

According to William Blair, the prior rating for Actinium Pharmaceuticals Inc (AMEX:ATNM) was changed from Outperform to Market Perform. In the third quarter, Actinium Pharmaceuticals showed an EPS of $0.38, compared to $0.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of $15.12 and a 52-week-low of $4.41. Actinium Pharmaceuticals closed at $13.76 at the end of the last trading period.

According to Piper Sandler, the prior rating for American Equity Investment Life Holding Co (NYSE:AEL) was changed from Overweight to Neutral. American Equity Inv earned $0.79 in the fourth quarter, compared to $1.04 in the year-ago quarter. The current stock performance of American Equity Inv shows a 52-week-high of $48.37 and a 52-week-low of $28.05. Moreover, at the end of the last trading period, the closing price was at $44.99.

Truist Securities downgraded the previous rating for Focus Financial Partners Inc (NASDAQ:FOCS) from Buy to Hold. For the fourth quarter, Focus Finl Partners had an EPS of $0.99, compared to year-ago quarter EPS of $0.94. At the moment, the stock has a 52-week-high of $53.53 and a 52-week-low of $30.27. Focus Finl Partners closed at $50.12 at the end of the last trading period.

Truist Securities downgraded the previous rating for Generac Holdings Inc (NYSE:GNRC) from Buy to Hold. For the fourth quarter, Generac Hldgs had an EPS of $1.78, compared to year-ago quarter EPS of $2.51. The stock has a 52-week-high of $329.50 and a 52-week-low of $86.29. At the end of the last trading period, Generac Hldgs closed at $126.77.

According to Stephens & Co., the prior rating for RE/MAX Holdings Inc (NYSE:RMAX) was changed from Overweight to Equal-Weight. In the fourth quarter, RE/MAX Hldgs showed an EPS of $0.41, compared to $0.60 from the year-ago quarter. At the moment, the stock has a 52-week-high of $31.60 and a 52-week-low of $17.03. RE/MAX Hldgs closed at $19.74 at the end of the last trading period.

Raymond James downgraded the previous rating for First Merchants Corp (NASDAQ:FRME) from Strong Buy to Outperform. In the fourth quarter, First Merchants showed an EPS of $1.19, compared to $0.89 from the year-ago quarter. At the moment, the stock has a 52-week-high of $45.04 and a 52-week-low of $34.07. First Merchants closed at $42.29 at the end of the last trading period.

According to Raymond James, the prior rating for First Commonwealth Financial Corp (NYSE:FCF) was changed from Outperform to Market Perform. In the fourth quarter, First Commonwealth showed an EPS of $0.39, compared to $0.37 from the year-ago quarter. At the moment, the stock has a 52-week-high of $16.68 and a 52-week-low of $12.76. First Commonwealth closed at $16.43 at the end of the last trading period.

For Cullen/Frost Bankers Inc (NYSE:CFR), Raymond James downgraded the previous rating of Outperform to Market Perform. Cullen/Frost Bankers earned $2.91 in the fourth quarter, compared to $1.54 in the year-ago quarter. The stock has a 52-week-high of $160.60 and a 52-week-low of $112.67. At the end of the last trading period, Cullen/Frost Bankers closed at $131.30.

For Constellation Energy Corp (NASDAQ:CEG), B of A Securities downgraded the previous rating of Buy to Neutral. At the moment, the stock has a 52-week-high of $97.89 and a 52-week-low of $42.18. Constellation Energy closed at $84.55 at the end of the last trading period.

UBS downgraded the previous rating for DocuSign Inc (NASDAQ:DOCU) from Neutral to Sell. In the third quarter, DocuSign showed an EPS of $0.57, compared to $0.58 from the year-ago quarter. The current stock performance of DocuSign shows a 52-week-high of $123.50 and a 52-week-low of $39.57. Moreover, at the end of the last trading period, the closing price was at $64.47.

For Eversource Energy (NYSE:ES), Wolfe Research downgraded the previous rating of Outperform to Peer Perform. In the fourth quarter, Eversource Energy showed an EPS of $0.92, compared to $0.91 from the year-ago quarter. The current stock performance of Eversource Energy shows a 52-week-high of $94.63 and a 52-week-low of $70.54. Moreover, at the end of the last trading period, the closing price was at $80.27.

For SentinelOne Inc (NYSE:S), Wells Fargo downgraded the previous rating of Overweight to Equal-Weight. SentinelOne earned $0.16 in the third quarter, compared to $0.15 in the year-ago quarter. The stock has a 52-week-high of $44.74 and a 52-week-low of $12.69. At the end of the last trading period, SentinelOne closed at $15.94.

For Cable One Inc (NYSE:CABO), Wells Fargo downgraded the previous rating of Equal-Weight to Underweight. For the third quarter, Cable One had an EPS of $11.53, compared to year-ago quarter EPS of $8.33. The current stock performance of Cable One shows a 52-week-high of $1576.49 and a 52-week-low of $620.57. Moreover, at the end of the last trading period, the closing price was at $753.38.

JP Morgan downgraded the previous rating for Sonic Automotive Inc (NYSE:SAH) from Overweight to Neutral. For the fourth quarter, Sonic Automotive had an EPS of $2.61, compared to year-ago quarter EPS of $2.66. The stock has a 52-week-high of $62.26 and a 52-week-low of $34.17. At the end of the last trading period, Sonic Automotive closed at $60.00.

According to JP Morgan, the prior rating for AutoNation Inc (NYSE:AN) was changed from Neutral to Underweight. In the fourth quarter, AutoNation showed an EPS of $6.37, compared to $5.76 from the year-ago quarter. The current stock performance of AutoNation shows a 52-week-high of $158.30 and a 52-week-low of $94.92. Moreover, at the end of the last trading period, the closing price was at $157.30.

For The Mosaic Co (NYSE:MOS), HSBC downgraded the previous rating of Hold to Reduce. Mosaic earned $3.22 in the third quarter, compared to $1.35 in the year-ago quarter. The current stock performance of Mosaic shows a 52-week-high of $79.28 and a 52-week-low of $40.29. Moreover, at the end of the last trading period, the closing price was at $49.85.

For CF Industries Holdings Inc (NYSE:CF), HSBC downgraded the previous rating of Buy to Hold. CF Industries Holdings earned $4.35 in the fourth quarter, compared to $3.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of $119.60 and a 52-week-low of $72.54. CF Industries Holdings closed at $82.35 at the end of the last trading period.

JMP Securities downgraded the previous rating for Claros Mortgage Trust Inc (NYSE:CMTG) from Market Outperform to Market Perform. Claros Mortgage Trust earned $0.38 in the fourth quarter, compared to $0.30 in the year-ago quarter. At the moment, the stock has a 52-week-high of $21.09 and a 52-week-low of $11.53. Claros Mortgage Trust closed at $14.85 at the end of the last trading period.

See all analyst ratings downgrades.

Initiations

With an Underperform rating, Autonomous Research initiated coverage on Ryan Specialty Holdings Inc (NYSE:RYAN). The price target seems to have been set at $35.00 for Ryan Specialty Holdings. In the third quarter, Ryan Specialty Holdings showed an EPS of $0.25, compared to $0.24 from the year-ago quarter. At the moment, the stock has a 52-week-high of $46.40 and a 52-week-low of $32.13. Ryan Specialty Holdings closed at $42.74 at the end of the last trading period.

With an Outperform rating, Noble Capital Markets initiated coverage on MAIA Biotechnology Inc (AMEX:MAIA). The price target seems to have been set at $14.00 for MAIA Biotechnology. The stock has a 52-week-high of $9.64 and a 52-week-low of $3.10. At the end of the last trading period, MAIA Biotechnology closed at $4.53.

Raymond James initiated coverage on TXO Energy Partners LP (NYSE:TXO) with a Strong Buy rating. The price target for TXO Energy Partners is set to $34.00. The current stock performance of TXO Energy Partners shows a 52-week-high of $23.47 and a 52-week-low of $21.28. Moreover, at the end of the last trading period, the closing price was at $22.66.

EF Hutton initiated coverage on Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) with a Buy rating. The price target for Alnylam Pharmaceuticals is set to $304.00. In the third quarter, Alnylam Pharmaceuticals showed an EPS of $1.58, compared to $1.59 from the year-ago quarter. The current stock performance of Alnylam Pharmaceuticals shows a 52-week-high of $242.97 and a 52-week-low of $117.58. Moreover, at the end of the last trading period, the closing price was at $222.79.

Needham initiated coverage on Cipher Mining Inc (NASDAQ:CIFR) with a Buy rating. The price target for Cipher Mining is set to $2.70. Cipher Mining earned $0.06 in the third quarter, compared to $0.01 in the year-ago quarter. The current stock performance of Cipher Mining shows a 52-week-high of $3.94 and a 52-week-low of $0.38. Moreover, at the end of the last trading period, the closing price was at $1.90.

With a Buy rating, Needham initiated coverage on Riot Platforms Inc (NASDAQ:RIOT). The price target seems to have been set at $9.00 for Riot Platforms. In the third quarter, Riot Platforms showed an EPS of $0.00, compared to $0.16 from the year-ago quarter. At the moment, the stock has a 52-week-high of $23.66 and a 52-week-low of $3.25. Riot Platforms closed at $6.59 at the end of the last trading period.

Stifel initiated coverage on TXO Energy Partners LP (NYSE:TXO) with a Buy rating. The price target for TXO Energy Partners is set to $31.00. At the moment, the stock has a 52-week-high of $23.47 and a 52-week-low of $21.28. TXO Energy Partners closed at $22.66 at the end of the last trading period.

With an Overweight rating, Piper Sandler initiated coverage on Galera Therapeutics Inc (NASDAQ:GRTX). The price target seems to have been set at $6.00 for Galera Therapeutics. In the third quarter, Galera Therapeutics showed an EPS of $0.60, compared to $0.86 from the year-ago quarter. At the moment, the stock has a 52-week-high of $2.75 and a 52-week-low of $1.12. Galera Therapeutics closed at $1.72 at the end of the last trading period.

With a Neutral rating, Citigroup initiated coverage on Biomarin Pharmaceutical Inc (NASDAQ:BMRN). The price target seems to have been set at $116.00 for Biomarin Pharmaceutical. In the third quarter, Biomarin Pharmaceutical showed an EPS of $0.04, compared to $0.20 from the year-ago quarter. At the moment, the stock has a 52-week-high of $117.77 and a 52-week-low of $70.73. Biomarin Pharmaceutical closed at $108.31 at the end of the last trading period.

See all analyst ratings initiations.

Posted In: AEL ALNY AN ATNM AX BMRN CABO CAL CEG CF CFR CIFR CMTG DOCU ES FCF FOCS FRME GBCI GNRC